## Most Common ESBL-Producing Gram-Negative Organism **Key Point:** Escherichia coli is the most frequent ESBL producer globally and in India, accounting for 40–60% of ESBL-producing gram-negative isolates in community and nosocomial settings. ### Epidemiology of ESBL Production | Organism | Prevalence as ESBL Producer | Common Source | Clinical Significance | |----------|---------------------------|---------------|----------------------| | E. coli | 40–60% (highest) | UTI, bloodstream | Community-acquired; high resistance | | K. pneumoniae | 20–35% | Respiratory, bloodstream | Nosocomial; often multidrug-resistant | | Proteus mirabilis | 5–10% | UTI | Less common ESBL producer | | Enterobacter aerogenes | <5% | Nosocomial | Rare ESBL producer | **High-Yield:** In India, ESBL-producing E. coli is the leading cause of community-acquired UTIs and is responsible for treatment failures with third-generation cephalosporins. ### Why E. coli Dominates ESBL Production 1. **Plasmid carriage**: E. coli readily acquires and maintains ESBL-encoding plasmids (TEM, SHV, CTX-M families). 2. **Horizontal gene transfer**: High rate of conjugation with other gram-negatives. 3. **Environmental reservoir**: Fecal carriage in community; spreads via contaminated food and water. 4. **Clinical prevalence**: Most common gram-negative UTI pathogen; ESBL prevalence in E. coli UTI isolates is 20–40% in India. **Clinical Pearl:** CTX-M-type ESBLs (especially CTX-M-15) are the most prevalent ESBL variant in E. coli worldwide and in India, often associated with community-acquired infections. ### Mnemonic: **ESBL Big Three** — **E**. coli, **K**lebsiella, **E**nterobacter (but E. coli is #1). [cite:Koneman's Textbook of Diagnostic Microbiology 13e Ch 8]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.